This summary was created by AI, based on 1 opinions in the last 12 months.
Adus Homecare Corp. has established itself as a leading provider of in-home and hospice care services, with a significant revenue stream originating from states such as Illinois, New York, and New Mexico. In 2023, the company made a strategic move to expand its footprint into Tennessee through the acquisition of a local firm, reflecting its growth ambitions and adaptability in the evolving healthcare landscape. The company reported strong financial results in February, surpassing expectations on both top and bottom lines. This performance indicates a positive trend in operational efficiency and demand for its services, positioning Adus Homecare favorably in the market as it continues to expand its reach and capabilities. Overall, the outlook appears to be strong as it builds on its existing foothold and explores new opportunities.
Adus Homecare Corp. is a American stock, trading under the symbol ADUS-Q on the NASDAQ (ADUS). It is usually referred to as NASDAQ:ADUS or ADUS-Q
In the last year, 1 stock analyst published opinions about ADUS-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Adus Homecare Corp..
Adus Homecare Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Adus Homecare Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 1 stock analyst on Stockchase covered Adus Homecare Corp.. The stock is worth watching.
On 2025-02-04, Adus Homecare Corp. (ADUS-Q) stock closed at a price of $123.02.
They provide in-home or hospice care. They get most revenues from Illinois, New York and New Mexico but bought a company to enter Tennessee in 2023. They delivered a strong top and bottom line beat last February. Great trend.